Sun, G., Chen, X., Pan, T., Song, K., Xie, H., Tu, M., . . . Zhu, X. Prophylactic infusion of allogeneic double-negative T cells as immune modulators to prevent relapse in high-risk AML patients post-Allo-HSCT: A phase I trial. BMC.
Chicago Style (17th ed.) CitationSun, Guangyu, et al. Prophylactic Infusion of Allogeneic Double-negative T Cells as Immune Modulators to Prevent Relapse in High-risk AML Patients Post-Allo-HSCT: A Phase I Trial. BMC.
MLA (9th ed.) CitationSun, Guangyu, et al. Prophylactic Infusion of Allogeneic Double-negative T Cells as Immune Modulators to Prevent Relapse in High-risk AML Patients Post-Allo-HSCT: A Phase I Trial. BMC.
Warning: These citations may not always be 100% accurate.